The German Center for Neurodegenerative Diseases (DZNE) is actively contributing to the efforts to limit and neutralise the impact of the Covid-19 outbreak. The DZNE has therefore started to apply…
DZNE researchers have developed a novel, experimental approach against Alzheimer’s based on the stimulation of immune cells of the brain by means of an antibody.
Munich scientists investigate new…
Two employees of the German Center for Neurodegenerative Diseases (DZNE) in Bonn have tested positive for the coronavirus SARS-CoV-2.
Bonn, March 9, 2020. Two employees of the German Center for…
Hilfe im Kampf gegen rätselhafte Lähmung
Etwa 8.000 Menschen in Deutschland sind von der Nervenkrankheit Amyotrophe Lateralsklerose (ALS) betroffen. Zum zweiten Informationstag am Samstag, 8.…
Dr. Dragomir Milovanovic awarded Whitman Center Early Career Investigator Award
Our Berlin group leader, Dr. Dragomir Milovanovic, was awarded the Whitman Center Early Career Investigator Award 2020…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
